Upgrade to SI Premium - Free Trial

Nuvectis Pharma (NVCT)

10.31 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/11/26)

Latest Headlines

Nuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ May 14, 2026 7:30 AM - Globe NewsWire Form 10-Q Nuvectis Pharma, Inc. For: Mar 31 May 5, 2026 9:03 AM - SEC Filing Form 8-K Nuvectis Pharma, Inc. For: May 05 May 5, 2026 7:36 AM - SEC Filing Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights May 5, 2026 7:30 AM - Globe NewsWire Form DEFA14A Nuvectis Pharma, Inc. April 27, 2026 4:40 PM - SEC Filing Form DEF 14A Nuvectis Pharma, Inc. For: Jun 11 April 27, 2026 4:37 PM - SEC Filing Nuvectis Pharma to present NXP900 data at 2026 cancer research meeting March 31, 2026 8:01 AM - StreetInsider Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting March 31, 2026 8:00 AM - StreetInsider Full Article List